Trifluridine-13C,15N2
Modify Date: 2024-01-14 11:03:13
Trifluridine-13C,15N2 structure
|
Common Name | Trifluridine-13C,15N2 | ||
|---|---|---|---|---|
| CAS Number | 2086328-10-9 | Molecular Weight | 299.18 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C913CH11F315N2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Trifluridine-13C,15N2Trifluridine-13C,15N2 is the 13C and 15N labeled Trifluridine[1]. Trifluridine (Trifluorothymidine;5-Trifluorothymidine;TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Trifluridine is an antiviral drug for herpes simplex virus (HSV) infection. Trifluorothymidine also has anti-orthopoxvirus activity[2]. |
| Name | Trifluridine-13C,15N2 |
|---|
| Description | Trifluridine-13C,15N2 is the 13C and 15N labeled Trifluridine[1]. Trifluridine (Trifluorothymidine;5-Trifluorothymidine;TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Trifluridine is an antiviral drug for herpes simplex virus (HSV) infection. Trifluorothymidine also has anti-orthopoxvirus activity[2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C913CH11F315N2O5 |
|---|---|
| Molecular Weight | 299.18 |